Sirolimus-Eluting Coronary Stent System
- UID
- IMP/MD/2020/000472_2d4f3fa0e5e4db6adf50e31497e27333_38540d417f8d22ff65feb3ca5121ddce
- Device class
- Class D
- Brand name
- Ultraskin
- License holder
- M/s LepuCare (India) Vascular Solutions Pvt. Ltd.,
- Approving authority
- CDSCO
- Product information
- The PARTNER® Stent is indicated for use in: • Patients eligible for balloon angioplasty with symptomatic ischemic heart disease due to discrete de novo and/or restenotic native coronary artery lesions with reference vessel diameters ranging from 2.5 mm to 4.0 mm, and with target vessel stenosis degree more than 70% , or having evident ischemic symptom and target lesion stenosis degree more than 50%. • Patients with acute occlusion or on the verge of occlusion during percutaneous coronary intervention. • Patients with significant residual stenosis after simple balloon dilatation • Patients with acute coronary syndromes
Sirolimus-Eluting Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2020/000472_2d4f3fa0e5e4db6adf50e31497e27333_38540d417f8d22ff65feb3ca5121ddce. This device is marketed under the brand name Ultraskin. The license holder is M/s LepuCare (India) Vascular Solutions Pvt. Ltd.,, and it is classified as Device Class Class D. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.